|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,570.00 INR | +2.64% |
|
+2.75% | -1.38% |
| 30/01 | Hester Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 | CI |
| 30/01 | Hester Biosciences Limited, Q3 2026 Earnings Call, Jan 30, 2026 |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 14Cr | ||
| 1.54% | 1.74% | 21.46x | 10.12x | 6.5x | 14.85x | 16.59x | 5.67TCr | ||
| -.--% | -.--% | -4502.63x | 1.97x | 3.48x | 18.23x | 21.29x | 1.28TCr | ||
| 2.15% | 2.03% | 21.42x | 1.74x | 1.96x | 9.38x | 16.43x | 474.51Cr | ||
| 0.45% | 0.5% | 19.36x | 2.53x | 2.11x | 10.53x | 13.31x | 353.88Cr | ||
| 0.25% | 0.57% | 92.82x | 3.22x | - | - | - | 249.46Cr | ||
| 0.93% | 0.93% | 21.25x | 5.58x | 1.76x | 10.47x | 12.51x | 208.83Cr | ||
| -.--% | -.--% | 38.57x | 1.68x | 3.45x | 12.36x | 17.91x | 149.58Cr | ||
| 2.57% | 2.85% | 19.57x | 1.89x | 2.59x | 11.14x | 16.34x | 126.85Cr | ||
| 1.02% | 1.07% | 17.76x | 1.65x | 1.53x | 7.63x | 10.26x | 121.9Cr | ||
| 1.02% | 1.15% | 32.71x | 1.41x | - | - | - | 115.97Cr | ||
| 0.48% | 0.86% | 30.13x | 2.81x | - | - | - | 78Cr | ||
| 0.9% | 2.43% | 59.35x | 0.48x | 1.91x | 10.16x | 28.86x | 41Cr | ||
| Average | 0.94% | 1.18% | -344.02x | 2.92x | 2.81x | 11.64x | 17.06x | 683.29Cr | |
| Weighted average by Cap. | 1.22% | 1.37% | -627.67x | 7.29x | 5.28x | 14.54x | 17.04x |
- Stock Market
- Equities
- HESTERBIO Stock
- Sector Hester Biosciences Limited
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















